Korea Republic Of to India: Syringe Import Trade Route

The Korea Republic Of to India Syringe corridor is one of India's established pharmaceutical import routes from Korea Republic Of, with 6 shipments documented worth a combined $933 USD. The route is dominated by NOBEL BIOCARE SERVICES AG, which alone accounts for roughly 94% of all import value, reflecting the consolidated nature of Korea Republic Of's syringe export sector.

Across 2 active Korea Republic Of suppliers, the average shipment value stands at $155 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with syringe's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 29.7%, placing it at rank #1 among India's top syringe import origins globally.

On the Indian buyer side, key Indian importers include NOBEL BIOCARE INDIA PRIVATE LIMITED, Importers importing goods for display or use in fa. NOBEL BIOCARE INDIA PRIVATE LIMITED is the single largest Indian importer with 4 shipments valued at $878 USD.

India's syringe imports from Korea Republic Of are driven primarily by a handful of large-scale Korea Republic Of manufacturers. NOBEL BIOCARE SERVICES AG with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — Indian buyers benefit from Korea Republic Of supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NOBEL BIOCARE SERVICES AG, EMT LOGISTICS INC — together account for 100% of total trade value on this route. The average shipment value of $155 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as creos dbbm syringe 0 2 1 0mm 0 50g dental filling material and creos dbbm syringe 1 0 2 0mm 0 25g dental filling material, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Korea Republic Of supplier.

On the buying side, NOBEL BIOCARE INDIA PRIVATE LIMITED is the largest importer with 4 shipments worth $878 USD — representing 94% of all syringe imports from Korea Republic Of on this route.